Archive for February, 2010

HemOnc approach to cancer

February 24, 2010

Matthew Cooney, MD, discusses the multidisciplinary approach to cancer treatment at the Department of Medicine at Case Western Reserve University.
Learn more about the Division of Hematoloy Oncology ::

Cardiovascular Medicine Research Innovation Video

February 24, 2010

CWRUmedicine’s Cardiovascular Medicine’s Research & Innovation Center is the largest biomedical research center in the state of Ohio, and one of the top 15 in the country.

Our Cardiovascular Research Center works specifically to improve the clinical diagnosis and treatment of cardiovascular diseases. We use translational research (the clinical application of scientific medical research from lab to bedside) and advancements in biomedicine to improve industry standards and quality of patient care.

Learn more at CWRUmedicine Cardiovascular Medicine

UH System Achievement Award for Time-is-Muscle CWRUmedicine’s Cardiovascular Medicine Committee door-to-balloon time initiative

February 24, 2010

This is a multi-disciplinary team effort from EMS/Transfer Center, ED, cath lab, CICU, and Quality Center.

Median D2B reduced from 94 to 37 min with 100 per cent of pts receiving AHA/ACC recommended D2B less than 90 min.

Key Department of Medicine MDs included Madan Mohan, Rich Jospehson, Tom Lassar, Shyam Bhakta, Tom Carrigan, Marco Costa, and Dan Simon.

Learn more about Cardiovascular Medicine at CWRUmedicine

CWRUmedicine’s HemOnc researchers publish new findings that may lead to a new standard of care for patients with locally advanced cervical cancer

February 24, 2010

Published in the February 2010 issue of Clinical Cancer Research, the phase one study found that a new chemotherapy medicine, Triapine, was well tolerated in combination with standard-of-care cisplatin chemotherapy and radiation treatment in women with cervical cancer. This regimen provided both significant reduction in cancer disease and cancer control.

“This new drug, which suppresses tumor growth, shows a great deal of promise for cervical cancer patients who are at high risk for relapse and cancer-related death,” says Charles Kunos, MD, Primary Investigator of the study, Director of Gynecologic Radiation Oncology at UH Case Medical Center and Assistant Professor at Case Western Reserve University School of Medicine. “In this ten-patient study, a 100% complete response rate was observed and no disease progression was documented through 18 months of median follow-up.”

In the study, patients were treated three times weekly with Triapine in combination with weekly cisplatin treatment and daily pelvic radiation therapy over five weeks. A phase two follow-up study is ongoing at the Ireland Cancer Center. UH Case Medical Center is the primary affiliate of Case Western Reserve University School of Medicine, a nationally recognized leader in medical research and education.

“Cervical cancer affects half a million women worldwide each year,” says Steven Waggoner, MD, Chief of Gynecologic Oncology at UH Case Medical Center and Assistant Professor at Case Western Reserve University School of Medicine. “We are pleased to have found a promising new treatment to help women fight this aggressive disease.”

Source :: NewsRx

CWRUmedicine Goals in Motion

February 24, 2010

See and download the full gallery on posterous

International Journal of Clinical Practice Most Read Article 2009

February 24, 2010

The Department of Medicine’s Dr. Clifford Packer’s editorial, “Cola-induced hypokalemia: a super-sized problem” was the most-read article in International Journal of Clinical Practice for the year 2009.

“Consider this curious case: a 44-year-old ostrich farmer from the Australian outback developed sudden onset of muscle weakness after returning home from an evening of kangaroo-shooting. He had difficulty in getting out of his bath and was unable to stand while waiting for help to arrive. His respiratory status deteriorated, and he required intubation and mechanical ventilation. He was found to be profoundly hypokalaemic with a serum potassium level of 1.4 mmol/l. He had been drinking 4 l of Coca-Cola per day over the past 3 years, and drank up to 10 l to slake his thirst when he went for kangaroo-shooting at night. He was advised to curtail his cola drinking, and his potassium level normalised, his weakness resolved, and he made a full recovery”

Full article

Congratulations to the Department of Medicine doctors who have been awarded the “Best Doctors” title by their peers.

February 24, 2010

The Department of Medicine would like to congratulate our doctors who have been recognised in Cleveland Magazine’s “Best Doctors” list.

We want to thank the entire community of CWRUmedicine physicians, nurses and staff for the work they do every day.

2010-bestdocsCardiovascular Medicine
Dr. Mauricio S. Arruda
Dr. John Blebea
Dr. Barry A. Effron
Dr. James Fang
Dr. Michel George Farah
Dr. Steven A. Fisher
Dr. Robert Goldstein
Dr. Austin A. Halle IIIte
Dr. Brian Hoit
Dr. Richard A. Josephson
Dr. Joseph I. Krall
Dr. Judith Mackall
Dr. Sri Krishna Madan Mohan
Dr. Carl E. Orringer
Dr. Aaron Proweller
Dr. Daniel I. Simon
Dr. Bruce S. Stambler
Dr. Albert L. Waldo

Clinical and Molecular Endocrinology
Dr. Baha Mahmoud Arafah

Gastroenterology and Liver Disease
Dr. Amitabh Chak
Dr. Fabio Cominelli
Dr. Gregory S. Cooper
Dr. Ashley L. Faulx
Dr. Gerard Isenberg
Dr. Jeffry A. Katz

Oncology and Hematology
Dr. Matthew M. Cooney
Dr. Brenda W. Cooper
Dr. Afshin Dowlati
Dr. Stanton L. Gerson
Dr. Joseph Gibbons
Dr. Smitha Subramanyan Krishnamurthi
Dr. Hillard Michael Lazarus
Dr. Nathan Levitan
Dr. Neal J. Meropol
Dr. Paula Silverman

Infectious Disease & HIV
Dr. Keith B. Armitage
Dr. Barbara M. Gripshover
Dr. Michael M. Lederman
Dr. Robert A. Salata

Nephrology & Hypertension
Dr. Donald E. Hricik
Dr. Daniel B. Ornt
Dr. Michael C. Smith

Pulmonary, Critical Care & Sleep
Dr. Rana B. Hejal
Dr. Hugo Montenegro
Dr. Robert John Schilz
Dr. Kingman P. Strohl